Voisard Asset Management Group’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-5	Closed	-$501	–	405
2024 Q3	$501	Buy	+5	New	+$501	﹤0.01%	588